Please Wait...

Case Studies

Recruitment

Alzheimer's Disease

Challenge:

Recruit and retain patients for a global study investigating a potential new treatment for Alzheimer's.

Click here to read more.

 

Pediatric Schizophrenia

Challenge:

Recruit children with schizophrenia, ages 13-17, for an FDA-mandated pediatric clinical study to evaluate an adult-approved medication for treatment of children with schizophrenia.

Click here to read more.

 

Chronic Pain Study

Challenge:

Patient recruitment, patient retention, and study coordinator site support to:

  • Motivate 55+ seniors to actively participate in a clinical study with a significant study burden – 3 endoscopies and a 7-month time commitment.
  • Communicate key benefits of study participation.
  • Keep study top of mind with local site study staff.

Click here to read more.

 

Retention

RAPSODI Study

Challenge:

Develop a comprehensive patient retention program to support both subjects and sites in a three-year, placebo-controlled, US-based study, with specific goals of reducing the 23% drop-out rate prior to program-launch and fostering compliance to this generally non-compliant population over the course of three years.

Click here to read more.

 

ALLEGRO Study

Challenge:

Develop a customized patient retention program that could be implemented swiftly to support sites in retaining patients over frequent study visits.

Click here to read more.

 

The ALFACHIN Study

Challenge:

Develop and localize study and patient retention materials quickly at significant cost savings for a global study for severely-afflicted patients. Specific goals included:

  • Designing a program that addressed the needs and interests of all pediatric participants.
  • Determining the most appropriate activities for a population coping with various degrees of paralysis.
  • Ensuring that the program was adaptable across multiple cultures and languages.

Click here to read more.

 

Rescue

Childhood Depression Study

Challenge:

Develop new message approach and support materials for a pivotal study which had expensed its recruitment budget with another provider and failed to meet recruitment objectives due to ineffective site support materials.

Click here to read more.

 

Nerve Pain Study

Challenge:

Develop a 'rescue strategy' for a clinical study that was not achieving its subject recruitment and retention objectives. Goals included:

  • Motivating both subjects and local site study staff to study completion.
  • Supporting select study sites through a 'patient advocacy' program directed at local community organizations.

Click here to read more.

 

ADDITIONAL RESOURCES

Patient Recruitment and Retention

Download Brochure

Alzheimer's Disease

Download Case Study

Pediatric Schizophrenia

Download Case Study

Chronic Pain Study

Download Case Study

RAPSODI Study

Download Case Study

ALLEGRO Study

Download Case Study

The ALFACHIN Study

Download Case Study

Childhood Depression Study

Download Case Study

Nerve Pain Study

Download Case Study

Global Clinical Research

Download Brochure

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (16 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (17 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (17 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (17 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (17 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (17 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices